Serum, Bharat Biotech to work together for 'smooth rollout' of Covid vaccines in India2 min read 05 Jan 2021, 02:59 PM IST
'The more important task in front of them is saving the lives and livelihoods of populations in India and the world,' the companies said
'The focus is on manufacturing, supply and distribution, such that populations that need it the most receive high quality, safe and efficacious vaccines,' the statement read
Days after India's drugs regulator approved emergency use authorization of Oxford COVID-19 vaccine Covishield, locally manufactured by Serum Institute of India and Bharat Biotech's indigenously manufactured Covaxin, both the vaccine manufacturers jointly communicated their pledge towards a 'smooth rollout' of COVID-19 vaccines to India and the world.
Select your Category